198 related articles for article (PubMed ID: 33653154)
1. Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.
Perdhana F; Kloping NA; Witarto AP; Nugraha D; Yogiswara N; Luke K; Kloping YP; Rehatta NM
Asian Cardiovasc Thorac Ann; 2021 Oct; 29(8):717-728. PubMed ID: 33653154
[TBL] [Abstract][Full Text] [Related]
2. A Reminder of Methylene Blue's Effectiveness in Treating Vasoplegic Syndrome after On-Pump Cardiac Surgery.
Manghelli J; Brown L; Tadros HB; Munfakh NA
Tex Heart Inst J; 2015 Oct; 42(5):491-4. PubMed ID: 26504450
[TBL] [Abstract][Full Text] [Related]
3. Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.
Peyko V; Finamore M
Am J Case Rep; 2021 Jun; 22():e930890. PubMed ID: 34143764
[TBL] [Abstract][Full Text] [Related]
4. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery.
Ozal E; Kuralay E; Yildirim V; Kilic S; Bolcal C; Kücükarslan N; Günay C; Demirkilic U; Tatar H
Ann Thorac Surg; 2005 May; 79(5):1615-9. PubMed ID: 15854942
[TBL] [Abstract][Full Text] [Related]
5. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery.
Levin RL; Degrange MA; Bruno GF; Del Mazo CD; Taborda DJ; Griotti JJ; Boullon FJ
Ann Thorac Surg; 2004 Feb; 77(2):496-9. PubMed ID: 14759425
[TBL] [Abstract][Full Text] [Related]
6. Methylene blue is associated with poor outcomes in vasoplegic shock.
Weiner MM; Lin HM; Danforth D; Rao S; Hosseinian L; Fischer GW
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1233-8. PubMed ID: 23972738
[TBL] [Abstract][Full Text] [Related]
7. Methylene Blue for Vasoplegic Syndrome After Cardiac Operation: Early Administration Improves Survival.
Mehaffey JH; Johnston LE; Hawkins RB; Charles EJ; Yarboro L; Kern JA; Ailawadi G; Kron IL; Ghanta RK
Ann Thorac Surg; 2017 Jul; 104(1):36-41. PubMed ID: 28551045
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery.
Lenglet S; Mach F; Montecucco F
Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1519-25. PubMed ID: 22103871
[TBL] [Abstract][Full Text] [Related]
9. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Datt V; Wadhhwa R; Sharma V; Virmani S; Minhas HS; Malik S
J Card Surg; 2021 Oct; 36(10):3749-3760. PubMed ID: 34251716
[TBL] [Abstract][Full Text] [Related]
10. Hydroxocobalamin or Methylene Blue for Vasoplegic Syndrome in Adult Cardiothoracic Surgery.
Kram SJ; Kram BL; Cook JC; Ohman KL; Ghadimi K
J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):469-476. PubMed ID: 34176677
[TBL] [Abstract][Full Text] [Related]
11. Hydroxocobalamin Versus Methylene Blue for Vasoplegic Syndrome in Cardiothoracic Surgery: A Retrospective Cohort.
Furnish C; Mueller SW; Kiser TH; Dufficy L; Sullivan B; Beyer JT
J Cardiothorac Vasc Anesth; 2020 Jul; 34(7):1763-1770. PubMed ID: 32115360
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative vasoplegia: methylene blue to the rescue!
McCartney SL; Duce L; Ghadimi K
Curr Opin Anaesthesiol; 2018 Feb; 31(1):43-49. PubMed ID: 29176374
[TBL] [Abstract][Full Text] [Related]
13. Vasoplegic syndrome--the role of methylene blue.
Shanmugam G
Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
[TBL] [Abstract][Full Text] [Related]
14. Methylene Blue for Vasoplegic Syndrome.
Booth AT; Melmer PD; Tribble B; Mehaffey JH; Tribble C
Heart Surg Forum; 2017 Oct; 20(5):E234-E238. PubMed ID: 29087290
[TBL] [Abstract][Full Text] [Related]
15. Methylene Blue for Vasoplegia When on Cardiopulmonary Bypass During Double-Lung Transplantation.
Carley M; Schaff J; Lai T; Poppers J
A A Case Rep; 2015 Oct; 5(8):127-30. PubMed ID: 26466303
[TBL] [Abstract][Full Text] [Related]
16. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
[TBL] [Abstract][Full Text] [Related]
17. Severe Vasoplegic Shock During Coronary Artery Bypass Surgery: Therapeutic challenges and Dilemmas in Hemodynamic Rescue.
Shah R; Wenger RK; Patel PA; Davis S; Ha B; Feinman JW; Patel S; Pulton D; Weiss SJ; Restrepo-Cardenas J; Aljure OD; Vasquez CR; Augoustides JG
J Cardiothorac Vasc Anesth; 2020 May; 34(5):1341-1347. PubMed ID: 32146101
[No Abstract] [Full Text] [Related]
18. After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery.
Evora PRB; Soares ROS; Bassetto S; Auxiliadora-Martins M; Silva FLDS; Basile A
Braz J Cardiovasc Surg; 2021 Jun; 36(3):406-411. PubMed ID: 34387976
[TBL] [Abstract][Full Text] [Related]
19. Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery: A Literature Review.
Nash CM
AACN Adv Crit Care; 2021 Jun; 32(2):137-145. PubMed ID: 34161970
[TBL] [Abstract][Full Text] [Related]
20. Methylene Blue Monotherapy Compared With Combination Therapy With Hydroxocobalamin for the Treatment of Refractory Vasoplegic Syndrome: ARetrospective Cohort Study.
Feih JT; Rinka JRG; Zundel MT
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1301-1307. PubMed ID: 30606508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
